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Abstract
This article is part of a series written for people responsible for making decisions about health policies and
programmes and for those who support these decision makers.
In this article, we address strategies to inform and engage the public in policy development and
implementation. The importance of engaging the public (both patients and citizens) at all levels of
health systems is widely recognised. They are the ultimate recipients of the desirable and
undesirable impacts of public policies, and many governments and organisations have acknowledged
the value of engaging them in evidence-informed policy development. The potential benefits of
doing this include the establishment of policies that include their ideas and address their concerns,
the improved implementation of policies, improved health services, and better health. Public
engagement can also be viewed as a goal in itself by encouraging participative democracy, public
accountability and transparency. We suggest three questions that can be considered with regard
to public participation strategies. These are: 1. What strategies can be used when working with the
mass media to inform the public about policy development and implementation? 2. What strategies
can be used when working with civil society groups to inform and engage them in policy
development and implementation? 3. What methods can be used to involve consumers in policy
development and implementation?
About STP
This article is part of a series written for people responsible for
making decisions about health policies and programmes and for
those who support these decision makers. The series is intended
to help such people ensure that their decisions are well-informed
by the best available research evidence. The SUPPORT tools
and the ways in which they can be used are described in more
detail in the Introduction to this series [1]. A glossary for the
entire series is attached to each article (see Additional File 1).
Links to Spanish, Portuguese, French and Chinese translations
of this series can be found on the SUPPORT website http://
www.support-collaboration.org.  Feedback about how to
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improve the tools in this series is welcome and should be sent to:
STP@nokc.no.
Scenario
The Minister of Health has promised to deliver a new health-
care reform. In declaring her intentions, the Minister has
emphasised the importance of engaging stakeholders in the
development of the proposal for the reform. You are a member
of the team responsible for developing the proposal and for
ensuring that key stakeholders are informed about relevant
research evidence and engaged effectively in evidence-informed
policy development.
Background
In this article, we present three questions that policymak-
ers and those who support them can ask when consider-
ing strategies to inform and engage the public in evidence-
informed policy development and implementation, such
as in the scenario described above.
Much of the terminology used to describe individuals
who come into contact with health systems is problematic
[2,3]. Words such as 'patient', 'client', 'consumer' and
'user' are commonly used, but may be misleading or con-
sidered unacceptable by those they are applied to. Several
of these terms, for example, implicitly suggest the exist-
ence of a market-based relationship and some people may
find this objectionable. Nonetheless, the term 'consumer'
is commonly used when describing approaches that
engage people in decisions about healthcare [4,5].
Healthcare 'consumers' can include patients, unpaid car-
ers, parents or guardians of patients, users of health serv-
ices, disabled people, members of the public who are the
potential recipients of either health promotion or public
health programmes, people who believe they have been
exposed to potentially harmful products or services, peo-
ple who believe they have been denied products or serv-
ices which they believe could have benefited them, as well
as those who pay for health services (e.g. as tax payers) [6].
Depending on the context, people can be described as 'lay'
people, 'non-experts', 'service users', 'members of the gen-
eral public' or as 'citizens'. In this article, we use the term
'the public' to include people in any of these various roles,
and the term 'consumer' when referring to individuals in
any of these roles.
The importance of engaging the public at all levels of
health systems is widely recognised. This is because mem-
bers of the public are the ultimate recipients of the effects
of health policy, both intended and unintended, and
many governments and organisations have acknowledged
the value of public engagement in policy development.
The potential benefits of doing this include the develop-
ment of policies that include their ideas or address their
concerns, the improvement of policy implementation,
better health services, and better health outcomes.
Public engagement can also be viewed as a goal in itself by
encouraging participative democracy, public accountabil-
ity and transparency. The World Health Organization's
Declaration of Alma Ata, for example, states that "... peo-
ple have the right and duty to participate individually and
collectively in the planning and implementation of their
health care" [7].
However, there is little evidence of the effects of engaging
the public in health policy [4,5,8-12]. Of the 42 papers
identified in a systematic review of public involvement in
the planning and development of health care, for
instance, 31 of these (74%) were case studies [8]. Often
these papers attributed the involvement of the public to
changes in services, including attempts to make services
more accessible. Changes in the attitudes of organisations
to involving the public and positive responses from con-
sumers who took part in initiatives were also reported.
Although this evidence suggested that public participation
may have contributed to changes in the provision of serv-
ices, such evidence was limited and came almost entirely
from high-income countries.
When considering strategies to inform and engage the
public in health policy development and implementa-
tion, it may be helpful to consider three broad strategy cat-
egories: those for working with the mass media (including
the use of interactive information and communication
technologies), those for working with civil society groups
(organisations representing various interests), and those
related to consumer involvement. As illustrated in Figure
1, effective engagement of the public in evidence-
Strategies to engage the public in evidence-informed health  policymaking Figure 1
Strategies to engage the public in evidence-informed 
health policymaking.
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informed health policymaking is likely to require a com-
bination of these overlapping strategies.
Questions to consider
The following questions can be considered when develop-
ing and implementing health policies:
1. What strategies can be used when working with the
mass media to inform the public regarding policy devel-
opment and implementation?
2. What strategies can be used when working with civil
society groups to inform and engage them in policy devel-
opment and implementation?
3. What methods can be used to involve consumers in
policy development and implementation?
1. What strategies can be used when working with the mass 
media to inform the public regarding policy development 
and implementation?
One way in which the public can be informed about (and
potentially engaged in) evidence-informed health policy
development is through the use of reports in the mass
media. These reports are able to receive wide coverage and
are an important source of information for the public, for
healthcare professionals, and for policymakers. Although
the impact of healthcare reporting is difficult to measure,
mass media can influence individual health behaviours,
levels of healthcare utilisation, healthcare practices, and
health policy [13-16]. Nevertheless, health technology
assessment (HTA) agencies, clinical practice guideline
developers and units that support the use of research evi-
dence in health policy have, thus far, generally made neg-
ligible efforts to communicate evidence to the wider
public in this way [17].
Journalists are likely to agree that the accurate reporting of
research related to health policy is important. However,
many are faced with constraints that may limit their abil-
ity to achieve this goal [18,19]. These obstacles may
include a lack of time, publishable space (or airtime) and
knowledge; competition for audiences; difficulties with
understanding and communicating jargon; problems
with finding and using sources; problems with editors
(who rarely have research training and may inhibit the
ability to report research accurately); and commercial
pressures (the need for journalists to sell their stories). As
a consequence, much health reporting is either inaccurate
or incomplete [20-24].
Mutual efforts by researchers and journalists are therefore
likely to be needed to address these constraints, and may
entail using a variety of strategies, including training, or
innovations such as structured press releases [25]. Well-
designed press releases could help to address the lack of
time, space and knowledge within the mass media, as well
as difficulties journalists may have with understanding
jargon. It is, however, unclear whether such strategies
could result in greater coverage for particular health issues
[26]. Understanding the constraints which journalists face
may also contribute to the design of more effective com-
munication strategies. These could, for example, reflect
recognition of the competing pressures of publishing
space and audiences, as well as issues related to finding
and using sources, or problems with editorial control.
Efforts that do not recognise these constraints in the mass
media are unlikely to be effective.
Possible strategies for working with the media to inform
the public about the development and implementation of
evidence-informed health policies include:
• Structured press releases: research press releases do not
routinely highlight study limitations, and data are often
presented using formats that may exaggerate the perceived
importance of findings [22,26]. Presentations comparable
to the format of the structured abstracts used in many
journals (which include a section for the contextual
description of the results, a section highlighting any limi-
tations, and a statement about potential conflicts of inter-
est) could help to ensure that journalists are given - and
are therefore more likely to report - key information
related to impact evaluations or other policy-relevant
research. Press releases for policy-relevant systematic
reviews could help to place research in context and shift
the focus of reporting from the latest (but often mislead-
ing) single study to a broader understanding of newswor-
thy research relevant to important policy decisions
[27,28]. Structures could also be used that are similar to
those provided in the summaries of systematic reviews
including, for example, key messages, a summary of key
findings, and a description of the basis for the informa-
tion used [29-32]. Similarly, press releases for policy briefs
might use a structure that mirrors the contents of a policy
brief, including structured sections with information
about how a problem is defined, the relevant policy
options and implementation strategies, and summaries of
the key messages about the underlying evidence [33]
￿ Fact boxes: information is often not reported about the
benefits and harms of clinical interventions and policy
options, or it is reported in ways that are uninformative or
may be misleading [22,23,26,34]. Standardised tables,
similar to a summary of findings tables, that quantify the
probability of outcomes together with different treat-
ments or policy options [35,36], could also be used to
enhance an understanding of the benefits, harms and
costs of different options, and the extent to which we can
be confident about those consequences [32,37,38]Health Research Policy and Systems 2009, 7(Suppl 1):S15 http://www.health-policy-systems.com/content/7/S1/S15
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￿ Press conferences: providing opportunities to question
those involved in policy development and decisions may
offer added value to journalists. The effectiveness of press
conferences can be maximised by: planning ahead (two to
three weeks where possible), timing the conference to
achieve maximum coverage (e.g. holding it in the morn-
ing for a suitable length of time, ensuring that the confer-
ence does not clash with other events), issuing invitations
that include all the relevant facts well in advance, ensuring
easy access to the press conference, preparing a press kit
(including a structured press release, fact boxes, relevant
background material, and suitable illustrations), and
ensuring that presentations are appropriately simple and
have clear messages [39]
￿ Providing stories: it is important for journalists to be able
to tell a story that will appeal to their audiences and also
be both easily understood and informative. Providing
journalists with appropriate anecdotes can facilitate this.
These can play a complementary role in research and can
facilitate the application of research evidence in health
care decisions [40]. Anecdotes can also be vehicles ena-
bling the delivery of research results to policymakers and
health professionals, as well as to the public. It is, how-
ever, important to ensure that anecdotes are used appro-
priately to personalise and illustrate research findings and
to present information in more meaningful ways. Con-
versely, it is important to ensure that anecdotes do not
conflict with the available evidence
￿ Avoiding jargon: unnecessary jargon should be avoided in
order to improve communication with journalists and the
public in turn. In instances where terminology is neces-
sary or useful, a glossary or the inclusion of fact boxes can
help to explain essential terms and thereby help to
improve reporting on important health policy issues.
Another strategy is to write about issues in plain language
first and then to introduce the relevant technical terms.
This allows readers to understand technical concepts more
clearly before seeing complex technical detail. The more
common alternative of using the technical term first and
providing a definition later, presents a barrier to immedi-
ate understanding and interrupts the flow of reading and
assimilation of ideas
￿ Providing access to experts: to facilitate good coverage of
important health policy issues it is important to identify
people with relevant expertise, including researchers who
are familiar with the research in question, as well as poli-
cymakers, stakeholders and people with a good under-
standing of relevant research or policy development
methods. Briefing experts who are familiar with the media
and can guide communication with the media may help
to ensure that key information is delivered in ways that are
understandable
￿ Tip sheets: providing journalists with simple questions to
consider and discuss when they are interviewing experts,
or researching or writing up stories, can help to ensure
that key questions are asked about health policy issues
and options, and that the answers are reported [21,41,42]
￿ Training: workshops or other types of training can help
journalists gain greater understanding of evidence-
informed health policymaking and to develop skills that
may help to improve the quality of health policy reporting
[19,43]. As a consequence, the extent to which the public
is well-informed and better able to engage in the develop-
ment and implementation of health policies may be
improved
In addition to working with traditional mass media, con-
sideration can be given to using new interactive informa-
tion and communication technologies (ICTs) - including
websites, blogs, and social networking sites - which are
becoming more and more important. However, a lack of
Internet access in some communities, particularly in low-
and middle-income countries, limits access to online pub-
lic engagement platforms. Infrastructural and cultural
contexts vary and require different models and
approaches. In addition, although the Internet is an
important and increasingly popular source of informa-
tion, policymakers face the challenge (similar to those in
other forms of mass media) of competing with vast
amounts of health information, some of which is neither
accurate nor complete [35,44]. Harnessing the full poten-
tial of ICTs to engage the public in evidence-informed
health policymaking therefore requires a mix of old and
new technologies and thoughtful planning.
An OECD report on the challenges of online citizen
engagement [45] proposes the following 10 strategies to
guide online consultation:
1. Start planning early
2. Demonstrate commitment to the online consulta-
tion and communicate this clearly
3. Guarantee personal data protection
4. Tailor your approach to fit your target group
5. Integrate online consultation with traditional meth-
ods
6. Test and adapt tools (e.g. software, questionnaires)
7. Promote your online consultationHealth Research Policy and Systems 2009, 7(Suppl 1):S15 http://www.health-policy-systems.com/content/7/S1/S15
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8. Ensure that sufficient time, resources and expertise
are available to provide thorough analysis of the input
received in the course of the online consultation
9. Publish the results of the online consultation as
soon as possible and inform participants of the next
steps in the policymaking process. Ensure that partici-
pants are informed of how the results were used in
reaching decisions
10. Evaluate the consultation process and its impacts
2. What strategies can be used when working with civil 
society groups to inform and engage them in policy 
development and implementation?
Civil society can be defined in a number of ways. In this
article, we use this term to refer to the wide range of organ-
isations outside the state. These may include patient
organisations, community groups, coalitions, advocacy
groups, faith-based organisations, charities or voluntary
organisations, professional associations, trade unions,
and business associations.
The National Institute for Health and Clinical Excellence
(NICE), based in the United Kingdom, has adopted a
comprehensive approach to involving the public and has
a programme with dedicated staff responsible for public
involvement [46-49]. NICE's efforts to involve stake-
holder organisations are far more extensive than that of
other clinical guideline developers. We are not aware of
similar programmes aimed at engaging stakeholder
organisations or civil society in the development or imple-
mentation of evidence-informed health policymaking. All
of the strategies used by NICE, however, could potentially
be applied to the engagement of civil society in evidence-
informed health policymaking. Civil society, for example,
could potentially be engaged in comparable stages for the
development and implementation of health policies, as
illustrated in Figure 2.
NICE includes the following organisations as stakehold-
ers in its clinical guideline development process [50]:
￿ National patient and carer organisations that directly or
indirectly represent the interests of people whose care is
covered by each guideline ('patient and carer stakehold-
ers')
￿ National organisations that represent healthcare profes-
sionals who provide the services described in each guide-
line ('professional stakeholders')
￿ Companies that manufacture the medicines or devices
used in the clinical area covered by each guideline and
whose interests may be significantly affected by each
guideline ('commercial stakeholders')
￿ Providers and commissioners of health services in Eng-
land, Wales and Northern Ireland
￿ Statutory organisations including the Department of
Health, the Welsh Assembly Government, National
Health Service (NHS) Quality Improvement Scotland, the
Healthcare Commission, and the National Patient Safety
Agency
￿ Research organisations that have done nationally-recog-
nised research in each relevant area
It may be important to engage a broader list of civil society
or stakeholder organisations for those health policies that
focus on health systems arrangements including, for
example, trade unions and business associations. NICE
alerts potential stakeholder organisations in a number of
ways and invites them to register their interest. These
alerts include the issuing of press releases, listing topics on
their website with details of how to register, contacting
organisations that have registered for previous guidance
to alert them to new topics, and writing to other patient,
carer and professional organisations that may have an
interest. NICE then contacts registered stakeholders and
encourages them to get involved in the development of
the different stages of such guidance. These include deter-
mining the scope of guidance, submitting evidence, com-
Engagement of civil society in stages in the policy develop- ment and implementation cycle* Figure 2
Engagement of civil society in stages in the policy 
development and implementation cycle. The numbers 
shown in brackets refer to the articles in this series 
(described in the Introduction [1]) which address the use of 
research evidence to inform each stage in the cycle
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menting on draft guidance, and checking guidance
revisions prior to publication.
Politicians and their constituency offices are likely to be
familiar with the potential challenges of working with
civil society, including claims that particular groups repre-
sent relevant patients or the public. Not all such groups do
so adequately. Many patient groups are primarily advo-
cacy groups that focus on obtaining resources for their
particular area of interest or on providing peer support,
rather than engaging in broader health policy issues [51].
And many patient organisations are funded by industry
and may therefore also have conflicting interests [52].
Professional organisations, too, may have similar con-
flicts of interest. Some, for example, may receive funds
from industry and be concerned primarily with the effects
of policies on their own members rather than on health or
the wider health care system.
3. What methods can be used to involve consumers in 
policy development and implementation?
Useful frameworks for describing and considering
approaches to consumer involvement have been devel-
oped including, for example, the framework presented by
Oliver and colleagues [4,5]. Similarly, Telford and col-
leagues have also developed a set of principles and indica-
tors for involvement [53]. While both of these approaches
have been developed in the context of consumer involve-
ment in research, they provide useful frameworks for con-
sidering public engagement in health policy development
and implementation.
The framework developed by Oliver and colleagues (Table
1) characterises diverse methods for involving consumers
based on the degree of involvement, the forum for com-
munication, involvement in decision making, the recruit-
ment of representatives, training, and financial support.
In their framework, the degree of involvement is classified
in three ways, namely consultation, collaboration and con-
sumer control. The process of consultation  entails asking
consumers for their views and using these to inform deci-
sion making. Policymakers or researchers, for example,
may hold one-off meetings with consumers to ascertain
their priorities or may write to consumers in accessible
terms to invite their views. Consumers' views, in such
instances, are not necessarily adopted although they may
inform the decisions taken.
Table 1: A framework for describing and considering approaches to consumer involvement*
Characteristics of different approaches Examples
Degree of consumer involvement • Consultation
• Collaboration
• Consumer control
Forum for communication • Written consultation
• Interviews
• Focus groups
• Consumer panels
• Committee membership
Involvement in decision making • No involvement
• Implicit involvement
• Explicit involvement
Recruitment • Targeted, personal invitations
• Wide advertising
• Use of mass media
• Contact by telephone, mail or email
Training and support • Education (e.g. workshops)
• Counselling
• Mentoring
• Introduction days
Financial support • No financial support
• Reimbursement of expenses
• Fee or honoraria
* Adapted from Oliver and colleagues [4]Health Research Policy and Systems 2009, 7(Suppl 1):S15 http://www.health-policy-systems.com/content/7/S1/S15
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Collaboration  entails active, ongoing partnerships with
consumers. For example, consumers may be committee
members (e.g. on the boards of health service organisa-
tions or regulatory committees) or they may collaborate
less formally. Again, there is no guarantee that consumers'
views will influence decisions, but collaboration offers
more opportunities for them to be heard than consulta-
tion. Formal methods of decision making may help to
ensure appropriate forms of collaboration [54]. Without
these it may be difficult to judge whether public involve-
ment has had any influence at all.
Consumer control, the third kind of consumer involvement
in the framework, entails consumers developing and
advocating or implementing health policies themselves.
Professionals are only involved at the invitation of the
consumers. In the context of public health systems this
might entail, for example, the inclusion of politicians who
are elected to represent their constituents.
Within this framework, methods are further distinguished
by descriptions of the forum for communication (such as
one-to-one interviews, focus groups, citizens' juries, town
meetings, committee meetings, and working groups) and
methods for decision making (such as informal commit-
tee consensus or voting). The presence or absence of trans-
parent descriptions of methods for decision making can
distinguish implied involvement in decisions (such as
participation in committee meetings) and explicit
involvement in decisions. Without transparent decision
making there is a risk that consumer involvement may be
regarded as tokenism.
Telford and colleagues used a consensus process to iden-
tify principles and indicators of successful consumer
involvement [53]. Each of the eight principles they identi-
fied can be measured by at least one clear indicator (see
Table 2). Although developed specifically to address the
involvement of consumers in research, these principles
and indicators are also relevant to public engagement in
policy development and implementation.
Conclusion
Policymakers, and those who support them, need to tailor
strategies for engaging the public in evidence-informed
policymaking to fit specific contexts, policies and key tar-
get groups. In poor countries, for example, radio may be
the most important mass media. The Internet offers new
opportunities for the interactive engagement of large
numbers of consumers in policy development and deci-
sions, and new ways to keep the public informed. Access
to the Internet, however, varies widely. It is therefore
important that the use of the Internet as a participation
tool should be supplemented with other strategies in
order to avoid exacerbating inequities in public engage-
ment.
For the public to be effectively engaged in evidence-
informed policymaking - and to avoid accusations of
token involvement and consultation - it is important that
Table 2: Principles and indicators of successful consumer involvement*
Principles Indicators
The roles of consumers are agreed • The roles of consumers were documented
The cost of consumer involvement is budgeted for • Consumers were reimbursed for their travel
• Consumers were reimbursed for their indirect costs (e.g. carer costs)
Policymakers respect the differing skills, knowledge and experience of 
consumers
• The contribution of consumers was reported
Consumers are offered training and personal support to enable their 
involvement
• Consumers were provided with training to enable their involvement
Policymakers ensure that they have the necessary skills to involve 
consumers effectively
• Policymakers were provided with training to enable them to involve 
consumers effectively
Consumers are involved in decision making • Consumers' advice was documented
• Consumers' role in decision making was documented
Consumer involvement is described in policy briefs • Consumers' contributions were described and acknowledged in policy 
briefs
Policy briefs are available to consumers in formats and languages they 
can easily understand
• Summaries of policy briefs were disseminated to consumers in 
appropriate formats
* Adapted from Telford and colleagues [53]Health Research Policy and Systems 2009, 7(Suppl 1):S15 http://www.health-policy-systems.com/content/7/S1/S15
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policymakers and those who support them carefully plan
and evaluate the strategies they use.
Resources
Useful documents and further reading
- Organisational self-assessment and planning tool for
consumer and community participation: a tool for organ-
isations involved in health policy and education. Version
1.0. 2003. http://www.healthissuescentre.org.au/docu
ments/items/2008/05/208317-upload-00001.pdf
- Crawford MJ, Rutter D, Manley C, Weaver T, Bhui K,
Fulop N, et al. Systematic review of involving patients in
the planning and development of health care. BMJ
2002;325:1263-7
- Nilsen ES, Myrhaug HT, Johansen M, Oliver S, Oxman
AD. Methods of consumer involvement in developing
healthcare policy and research, clinical practice guidelines
and patient information material. Cochrane Database of
Systematic Reviews 2006, Issue 3
Links to websites
- International Alliance of Patients' Organizations (IAPO):
http://www.patientsorganizations.org - A global alliance
of patients' organisations working at international,
regional, national and local levels to represent and sup-
port patients, their families and carers.
- Association of Health Care Journalists (AHCJ): http://
www.healthjournalism.org/index.php - An independent,
non-profit organisation dedicated to advancing public
understanding of health care issues. Its mission is to
improve the quality, accuracy and visibility of health care
reporting, writing and editing.
- INVOLVE is a national advisory group, funded by the
National Institute for Health Research (NIHR): http://
www.invo.org.uk/index.asp - Supports and promotes
active public involvement in NHS, public health and
social care research.
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